Branding, FDA Approval, Generic Pharmaceutical and Marketing

Search:

DAY

WEEK

MONTH

YEAR

Select your country:
Sign up | Log in

Branding

FDA Approval

Generic Pharmaceutical

Marketing

FDA Approves First Generic of Symbicort to Treat Asthma and COPD

The Pharma Data

MARCH 15, 2022

“Today’s approval of the first generic for one of the most commonly prescribed complex drug-device combination products to treat asthma and COPD is another step forward in our commitment to bring generic copies of complex drugs to the market, which can improve quality of life and help reduce the cost of treatment,” said Sally Choe, Ph.D.,

FDA Approval

FDA Approval Generic Drugs Production Drugs

Novartis’ Sandoz Launches Biosimilars Awareness Campaign to Improve Biosimilars Adoption Worldwide

XTalks

JUNE 8, 2022

Sandoz is a pioneering leader in generic pharmaceuticals and biosimilars, as Sandoz launched the world’s first biosimilar in Europe in 2006 and won the first biosimilar approval in the US in 2014. Related: Cyltezo Becomes First FDA-Approved Interchangeable Humira Biosimilar. billion in 2021 to a high of $44.7

Generic Pharmaceutical

Generic Pharmaceutical Production Branding Medicine

Clinical Research Informer

FDA Approves First Generic of Symbicort to Treat Asthma and COPD

Novartis’ Sandoz Launches Biosimilars Awareness Campaign to Improve Biosimilars Adoption Worldwide

Stay Connected